--- name: method-selection description: Selects the appropriate research framework and analytical tools for biomedical, market, investment, CMC/GMP, clinical, R&D, BD, and management consulting topics instead of defaulting to MECE or McKinsey-style framing. --- # Method Selection Use this skill before Phase 0-1 framing and whenever the user changes the report purpose. ## Principle Do not default to McKinsey/MECE. MECE, SCQA, and pyramid writing are useful communication tools, not universal research methods. Select the method based on: - report purpose - audience - decision to support - available materials - evidence type - regulatory or scientific risk - output format ## Method Router ### Market, investment, or commercial strategy Use when the user asks about market opportunity, competition, investment thesis, BD opportunity, pricing, or commercialization. Methods and tools: - market sizing: TAM/SAM/SOM, bottom-up demand model, volume-price bridge - competitive landscape: segmentation, product differentiation, launch timing, share shifts - value chain: upstream supply, manufacturing bottlenecks, channel economics - investment: thesis tree, scenario analysis, sensitivity analysis, risk-adjusted NPV where feasible - transaction/BD: deal comps, licensing terms, patent cliff, strategic fit Outputs: - market map - competitor table - assumptions ledger - upside/base/downside scenarios ### Clinical, translational, or evidence review Use when the topic is efficacy, safety, trial design, disease area, standard of care, biomarker, or clinical development. Methods and tools: - PICO or PICOTS framing - evidence hierarchy - endpoint and comparator analysis - trial design critique - TPP and go/no-go criteria - benefit-risk assessment Outputs: - clinical evidence matrix - trial landscape - endpoint comparability table - evidence gaps and patient-selection risks ### CMC, GMP, quality, or manufacturing operations Use when the topic involves process development, tech transfer, validation, inspection readiness, deviations, CAPA, sterility assurance, supply chain, or manufacturing risk. Methods and tools: - ICH / FDA / EMA / NMPA regulatory baseline mapping - gap assessment - FMEA or risk matrix - process validation lifecycle - control strategy mapping - deviation/CAPA effectiveness review - data integrity assessment Outputs: - gap register - risk heatmap - CAPA prioritization - control strategy map - readiness scorecard ### R&D feasibility or technology assessment Use when the topic asks whether a technology, target, modality, platform, assay, or process is feasible. Methods and tools: - technology readiness level - critical path analysis - mechanism and modality fit - experiment roadmap - scale-up risk assessment - IP and freedom-to-operate screening Outputs: - feasibility scorecard - key experiments - kill criteria - technical risk register ### Management, organization, or operating model Use when the topic involves organization, governance, operating cadence, capability building, performance management, or transformation. Methods and tools: - issue tree - operating model design - RACI / decision rights - KPI tree - process maturity assessment - change management roadmap Outputs: - operating model options - capability gap assessment - implementation roadmap - KPI and governance model ### Policy, regulation, or access environment Use when the topic asks about policy, reimbursement, regulatory pathways, pricing access, or regional rules. Methods and tools: - policy timeline - stakeholder map - regulatory pathway comparison - access and reimbursement framework - scenario analysis by jurisdiction Outputs: - jurisdiction comparison - policy impact map - regulatory milestone table - access risks ## Phase 0-1 Output Requirements Write a method decision note in `phase1/research_brief.md`: - selected method - why it fits - methods rejected and why - evidence types needed - search routes - expected output artifacts If the topic spans multiple scenarios, combine methods explicitly and define which chapters use which method.